Skip to main content
Premium Trial:

Request an Annual Quote

Danaher: Jose-Carlos Gutierrez-Ramos

Danaher has named Jose-Carlos Gutierrez-Ramos as its chief scientific officer and senior VP. He will be an executive officer of the company tasked with defining Danaher's science and technology strategy. He joins Danaher from Abbvie, where he served as head of global drug discovery. Gutierrez-Ramos also previously served as president and CEO of Repertoire Immune Medicines and Synlogic, and prior to that held R&D positions at Pfizer, GlaxoSmithKline, Avidia, and Millennium Pharmaceuticals. He also was a professor at Harvard Medical School in the Department of Genetics and a professor for the Spanish Scientific Research Council.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.